Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

After starting therapy for psoriasis, Asempa usually has a follow-up visit at 3 to 4 months. Patient feedback at that point carries a lot of weight with respect to next steps.

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

After two years, 1 in 4 people with psoriasis change from one biologic to another. Doing so can help improve your quality of life. Here’s what to know if you have to make a switch. [1] ...

Autoimmune diseases, especially in women, are associated with nearly a twofold increased risk for affective disorders, new ...

That will open up more cap space to sign other players that can help improve secondary scoring, an area that the Maple Leafs have struggled with over the last few years.

Psoriasis often affects the scalp, elbows, and knees, but it can also involve more sensitive areas like the face, palms, soles of the feet, armpits, groin, genitals, and underneath the breasts ...

Psoriasis severity is significantly associated with risk for restless leg syndrome, insomnia, and obstructive sleep apnea. HealthDay News — Both mild and moderate-to-severe psoriasis are significantly ...